THIRAT CHAKAVANMONGKOL: Open Payments
NPI 1265188221 · NORTH HOLLYWOOD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$396 in 15 payments from 6 companies in 2025. Trend: 2023 $873 · 2024 $924 · 2025 $396
Food & beverage: $396
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $226 |
| Novo Nordisk Inc | 3 | $70 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $35 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $34 |
| ABBVIE INC. | 1 | $15 |
| Amgen Inc. | 1 | $15 |
Products named: AIRSUPRA, Ozempic, FARXIGA, Kerendia, XIFAXAN, DALVANCE, OTEZLA.
Industry payments across CA — which companies pay providers there.
